| 624 |
Centers for Disease Control and Prevention |
Html |
en |
What are the Reasons to Vaccinate My Baby? | CDC Features |
Protecting your child's health is very important to you. That's why most parents choose immunization. Nothing protects babies better from 14 serious childhood diseases. Choose immunization. It's the powerful defense that's safe, prove, and effective. |
| vaccine recommendations | 0.463934 |
| American Academy | 0.534996 |
| child needs | 0.465934 |
| administration fee | 0.525453 |
| public health achievements | 0.562859 |
| children | 0.605371 |
| VFC vaccine | 0.46458 |
| young children | 0.47042 |
| vaccination rates | 0.44194 |
| devastating effects diseases | 0.582627 |
| eligible child | 0.484642 |
| childhood diseases | 0.590318 |
| large measles | 0.506371 |
| sick child | 0.461031 |
| diseases | 0.672987 |
| public health experts | 0.546557 |
| Learn ways | 0.436327 |
| safest vaccine supply | 0.593855 |
| vaccine website | 0.459604 |
| child | 0.849867 |
| United States can—and | 0.570168 |
| Unvaccinated travelers | 0.435784 |
| United States | 0.950185 |
| vaccines | 0.897516 |
|
| vaccine-preventable disease | 0.437872 |
| U.S. childhood immunization | 0.58875 |
| following eligibility requirements | 0.527241 |
| vfc program | 0.51452 |
| expensive medical bills | 0.528433 |
| measles cases | 0.503715 |
| Immunization Practices | 0.473997 |
| VFC vaccines | 0.594792 |
| powerful defense | 0.456502 |
| eligible children | 0.537275 |
| public health | 0.56818 |
| health insurance plans | 0.530587 |
| international travel | 0.442261 |
| unvaccinated people | 0.439436 |
| young parents | 0.440149 |
| certain vaccines | 0.587782 |
| baby proof | 0.450745 |
| new places | 0.45318 |
| childhood immunization schedule | 0.79767 |
| vaccine-preventable diseases | 0.456686 |
| family | 0.44608 |
| past decade | 0.440255 |
| measles | 0.574368 |
| childhood vaccines | 0.604867 |
|
CLICK HERE |
| 5040 |
Centers for Disease Control and Prevention |
Html |
en |
Assessing Your Weight: BMI: BMI Formula for Children and Teens | DNPAO | CDC |
null |
| centimeters | 0.657886 |
| ounces | 0.305254 |
| alternate calculation formula | 0.861648 |
| weight | 0.612581 |
| oz | 0.283662 |
| meters | 0.425063 |
| result | 0.286175 |
| inches | 0.408247 |
|
| pounds | 0.399155 |
| kilograms | 0.749656 |
| fractions | 0.29389 |
| lbs | 0.295266 |
| conversion factor | 0.545978 |
| height | 0.966023 |
| English measurements | 0.545313 |
|
CLICK HERE |
| 5573 |
Centers for Disease Control and Prevention |
Html |
en |
Phenyl glycidyl ether - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6482 |
Centers for Disease Control and Prevention |
Html |
en |
A statewide observational assessment of the pedestrian and cycling environment in Hawaii, 2010 |
Our statewide study was undertaken to assess how accessible and friendly Hawaii roads are to walking and bicycling. |
| study | 0.454301 |
| low-capacity roads | 0.945795 |
| United States | 0.461402 |
| pedestrian support | 0.446648 |
| randomly selected road | 0.425163 |
| friendly Hawaii roads | 0.522129 |
| pedestrian signals | 0.560418 |
| Transportation Equity Act | 0.477192 |
| Environmental Systems Research | 0.468697 |
| Pedestrian Environmental Data | 0.540108 |
| Complete Streets | 0.572762 |
| SD | 0.540317 |
| Systems Research Institute | 0.470951 |
| policy changes | 0.429424 |
| high-capacity roads | 0.755037 |
| road segments | 0.656398 |
| pedestrian traffic | 0.502917 |
| active transportation | 0.56121 |
| pedestrian accommodations | 0.542954 |
| state | 0.469031 |
| bicycle accommodations | 0.483591 |
| single-family houses | 0.451307 |
| pedestrian crossing aids | 0.490566 |
|
| office buildings | 0.453035 |
| Safe Routes | 0.462638 |
| Hawaii Geographic Information | 0.425554 |
| street segments | 0.61681 |
| Honolulu County | 0.553612 |
| interrater reliability | 0.745682 |
| Hawaii | 0.626779 |
| pedestrians | 0.529489 |
| Kauai | 0.461485 |
| Bicycling facilities | 0.422198 |
| pedestrian access | 0.460789 |
| traffic control devices | 0.423635 |
| physical activity | 0.449909 |
| major roads maps | 0.475356 |
| industrial buildings | 0.511228 |
| Pedestrian Environment Data | 0.518496 |
| apartment complexes | 0.512381 |
| High-capacity road segments | 0.486138 |
| bicycling environment | 0.483388 |
| bicycling infrastructure | 0.654772 |
| bicycle traffic | 0.444827 |
| pedestrian paddles | 0.493932 |
| major road segment | 0.451645 |
|
CLICK HERE |
| 7947 |
Centers for Disease Control and Prevention |
Html |
en |
Infant Meningococcal Vaccination: Advisory Committee onImmunization Practices ACIP Recommendations and Rationale |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| meningococcal disease outbreak | 0.703428 |
| ACIP meeting.* | 0.558711 |
| measurable meningococcal serogroups | 0.700769 |
| quadrivalent meningococcal vaccines | 0.722918 |
| meningococcal vaccine products | 0.685138 |
| sickle cell disease | 0.61829 |
| different Hib vaccine | 0.573806 |
| meningococcal disease outbreaks | 0.692254 |
| meningococcal vaccination | 0.792149 |
| increased risk | 0.573314 |
| routine meningococcal vaccination | 0.73096 |
| pneumococcal conjugate vaccine | 0.591953 |
| infants | 0.704916 |
| Meningococcal groups | 0.690402 |
| Certain infants | 0.563879 |
| Hib-MenCY-TT | 0.663932 |
| meningococcal disease | 0.946934 |
| ACIP Deliberations | 0.562034 |
| hSBA titers т‰Ѕ1 | 0.612723 |
| toxoid conjugate vaccine | 0.568628 |
| infant meningococcal vaccination | 0.752363 |
| Meningococcal Vaccines Work | 0.718846 |
| meningococcal vaccine | 0.759865 |
| infant vaccination schedule | 0.572877 |
| United States | 0.608312 |
|
| dose Hib immunization | 0.574096 |
| meningococcal vaccines | 0.760504 |
| control vaccine group | 0.560199 |
| healthy infants | 0.595934 |
| meningococcal conjugate vaccine | 0.752581 |
| potential increased risk | 0.557759 |
| ACIP | 0.635863 |
| congenital heart disease | 0.559952 |
| meningococcal cases | 0.6585 |
| serum bactericidal activity | 0.573018 |
| meningococcal vaccination recommendations | 0.71353 |
| quadrivalent meningococcal conjugate | 0.720663 |
| meningococcal conjugate vaccination | 0.705802 |
| quadrivalent meningococcal vaccine | 0.726066 |
| meningococcal clinical endpoint | 0.691811 |
| U.S. infants | 0.581701 |
| Hib vaccine | 0.593288 |
| unpublished data | 0.574321 |
| meningococcal serogroups | 0.762894 |
| ACIP meeting | 0.594154 |
| Hib-MenCY-TT vaccination | 0.565559 |
| meningitis belt | 0.560673 |
| meningococcal vaccination program | 0.736489 |
| work group | 0.563421 |
|
CLICK HERE |
| 10912 |
Centers for Disease Control and Prevention |
Html |
en |
Colorectal Cancer Screening Tests |
Descriptions of colorectal (colon) cancer screening tests, including high-sensitivity fecal occult blood testing (FOBT), sigmoidoscopy, colonoscopy, double-contrast barium enema, virtual colonoscopy, and stool DNA tests. |
| entire colon | 0.566366 |
| entire bowel movement | 0.546275 |
| Task Force | 0.636916 |
| U.S. Preventive Services | 0.620648 |
| stool DNA test | 0.739651 |
| test kit | 0.514565 |
| screening tests | 0.567025 |
| health care provider | 0.563557 |
| cancer cells | 0.33994 |
| flexible sigmoidoscopy | 0.35705 |
| chemical guaiac | 0.357588 |
| lighted tube | 0.584986 |
| increased risk | 0.365057 |
| following colorectal cancer | 0.646393 |
| polyps | 0.423616 |
|
| colorectal cancer | 0.942261 |
| guaiac-based fecal occult | 0.598687 |
| test | 0.928995 |
| fecal immunochemical test | 0.634748 |
| blood test | 0.387629 |
| following tests | 0.34448 |
| virtual colonoscopy | 0.354665 |
| best test | 0.363552 |
| doctor | 0.644748 |
| FIT-DNA test | 0.3811 |
| follow-up test | 0.365127 |
| doctor checks | 0.344722 |
| individual basis | 0.378267 |
| rectum | 0.308555 |
|
CLICK HERE |
| 11080 |
Centers for Disease Control and Prevention |
Html |
en |
Patient Safety Basics - Dialysis Safety |
Basic information for patients about dialysis |
| healthcare providers | 0.421418 |
| catheter bandage | 0.492768 |
| fewer problems | 0.448215 |
| patient resource | 0.422535 |
| graft | 0.37331 |
| death | 0.324355 |
| alcohol-based hand sanitizer | 0.541414 |
| important bodily functions | 0.584782 |
| kinds | 0.323603 |
| kidneys | 0.390333 |
| tips | 0.342454 |
| central line catheter | 0.769613 |
| pus | 0.323665 |
| critical functions | 0.455932 |
| hemodialysis patients | 0.633747 |
| fistulas | 0.436355 |
| signs | 0.34502 |
| ways | 0.326219 |
| vascular access site | 0.535017 |
| hemodialysis machine | 0.548231 |
| infections | 0.689104 |
| central line catheters | 0.78703 |
| vascular access daily | 0.54834 |
|
| Spanish | 0.323387 |
| arm | 0.350997 |
| Staphylococcus aureus | 0.446019 |
| two-sided guide outlines | 0.547054 |
| viral hepatitis | 0.435418 |
| chest | 0.326563 |
| dialysis treatment | 0.443057 |
| artery | 0.360958 |
| bloodstream infections | 0.545468 |
| English | 0.323373 |
| following resources | 0.443607 |
| risks | 0.323631 |
| fistula | 0.422579 |
| piece | 0.324894 |
| dialysis infections | 0.610035 |
| grafts | 0.43365 |
| risk | 0.324196 |
| infections rates | 0.549863 |
| large vein | 0.454053 |
| redness | 0.323679 |
| soft tube | 0.430757 |
| support | 0.328095 |
| central line | 0.949625 |
|
CLICK HERE |
| 11152 |
Centers for Disease Control and Prevention |
Html |
en |
Key Findings: Differences in Major Birth Defects | Birth Defects | NCBDDD | CDC |
null |
| North Carolina | 0.431 |
| Marengo LK | 0.431788 |
| spina bifida | 0.433654 |
| Asian Indians | 0.431843 |
| National Birth Defects | 0.552541 |
| time period | 0.430707 |
| ethnic groups | 0.526506 |
| comprehensive study | 0.435156 |
| major birth defects | 0.592502 |
| certain birth defects | 0.543528 |
| state tracking systems | 0.451936 |
| Defects Prevention Network | 0.515901 |
| largest study | 0.441525 |
| Canfield MA | 0.430648 |
| Flood TJ | 0.429246 |
| significantly higher occurrences | 0.468478 |
| new study | 0.441111 |
| Olney RS | 0.430901 |
| substantial variation | 0.432475 |
| American Journal | 0.462816 |
| Alverson CJ | 0.431758 |
| american indians/alaska natives | 0.513407 |
| Defects Prevention Study | 0.524053 |
| wide range | 0.429798 |
| population-based birth defects | 0.543389 |
|
| Public Health | 0.434824 |
| United States | 0.51646 |
| study area | 0.453096 |
| Evaluate Pregnancy exposures | 0.453931 |
| Borger CL | 0.431108 |
| Birth Defects Research | 0.530845 |
| state-based birth defects | 0.560825 |
| live birth | 0.44348 |
| different rates | 0.432766 |
| CDC funds | 0.43342 |
| non-Hispanic whites | 0.478791 |
| complete picture | 0.431366 |
| New York | 0.430349 |
| Birth Defects Study | 0.535403 |
| relatively high occurrence | 0.464029 |
| Asian subgroups | 0.43151 |
| Population-based means | 0.43427 |
| Hispanic subgroups | 0.431468 |
| birth defects | 0.900741 |
| Birth Defects Prevention | 0.552513 |
| significantly lower occurrence | 0.468677 |
| ethnic variation | 0.436521 |
| live U.S. births | 0.461322 |
| Kirby RS | 0.430373 |
|
CLICK HERE |
| 12185 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Prevalence of Sleep Duration onan Average School Night Among 4 Nationally RepresentativeSuccessive Samples of American High School Students, 2007-2013 -CDC |
Consistency, quality, and duration of sleep are important determinants of health. We describe sleep patterns among demographically defined subgroups from the Youth Risk Behavior Surveillance System reported in 4 successive biennial representative samples of American high school students (2007 to 2013). Across the 4 waves of data collection, 6.2% to 7.7% of females and 8.0% to 9.4% of males reported obtaining 9 or more hours of sleep. Insufficient duration of sleep is pervasive among American high school students. Despite substantive public health implications, intervention research on this topic has received little attention. |
| Hispanic males | 0.580318 |
| significantly higher percentage | 0.609875 |
| student response rate | 0.493366 |
| high school populations | 0.50444 |
| substantive public health | 0.509258 |
| overall response rate | 0.489399 |
| American high school | 0.925118 |
| white males | 0.607549 |
| larger percentage | 0.482466 |
| Youth Risk Behavior | 0.601964 |
| 12th graders | 0.541131 |
| intervention research | 0.498435 |
| sleep patterns | 0.652719 |
| William Paterson University | 0.579381 |
| higher percentage | 0.63022 |
| response rate | 0.524305 |
| disease risk factors | 0.482093 |
| black males | 0.581257 |
| especially black females | 0.555894 |
| black females | 0.730279 |
| school night | 0.603788 |
| Columbia University | 0.532622 |
| significantly greater percentage | 0.533506 |
| school response rate | 0.509808 |
| sleep benefits memory | 0.603015 |
|
| Teachers College | 0.500597 |
| New York University | 0.573789 |
| white females | 0.617838 |
| Hispanic females | 0.562581 |
| demographically defined subgroups | 0.613749 |
| significantly lower percentage | 0.530409 |
| institutional review boards | 0.493116 |
| sleep | 0.919973 |
| biennial representative samples | 0.500563 |
| successive biennial samples | 0.497236 |
| newly encoded memory | 0.482884 |
| sleep duration item | 0.644347 |
| average school night | 0.584907 |
| national population proportions | 0.495978 |
| Charles E. Basch | 0.487093 |
| important determinants | 0.51514 |
| little attention | 0.500802 |
| New York | 0.660896 |
| recent research | 0.498894 |
| high school students | 0.989075 |
| data collection | 0.5576 |
| Corey H. Basch | 0.48528 |
| York University Langone | 0.504676 |
| Risk Behavior Surveillance | 0.598312 |
|
CLICK HERE |
| 14441 |
Centers for Disease Control and Prevention |
Html |
en |
Skin Cancer Screening |
The U.S. Preventive Services Task Force (USPSTF) has concluded there is not enough evidence to recommend for or against routine screening to find skin cancers early. |
| skin cancer | 0.97684 |
| routine screening | 0.764995 |
| unusual moles | 0.734128 |
| evidence | 0.450341 |
| Force | 0.439917 |
| changes | 0.434348 |
| recommendation | 0.464084 |
| Consumer Guide | 0.609983 |
| history | 0.435763 |
| skin cancers | 0.664855 |
|
| Skin Cancer Screening | 0.836885 |
| people | 0.435963 |
| USPSTF | 0.656294 |
| doctor | 0.494895 |
| total body examination | 0.868686 |
| U.S. | 0.440061 |
| suspicious moles | 0.774059 |
| spots | 0.455126 |
| National Cancer Institute | 0.773447 |
|
CLICK HERE |